INT MEDICAL (01501) announced that on April 29, 2026, the company plans to acquire a 35% equity interest in Pulim Medical from Ms. Li Xiaoling, Ms. Chen Xiao, and Ms. Li Shaowei. The total consideration, including tax, amounts to 31.2853 million yuan. Upon completion of the equity acquisition, Pulim Medical will become a wholly-owned subsidiary of the company. Pulim Medical is a significant subsidiary primarily responsible for the market promotion and sales of the Group's medical devices in China. The Board of Directors believes the acquisition aligns with the company's strategic development objectives and will help enhance the Group's overall operational control and business synergy efficiency. Following the acquisition, the company will fully leverage Pulim Medical's specialized and standardized advantages in the medical device sales sector, integrate its managed projects, and continuously improve operational effectiveness to boost the company's overall sustainable development.